kabutan

DAIICHI SANKYO rises for third straight day on sale of healthcare unit to Suntory Holdings

Thu Apr 16, 2026 9:18 am JST Catalyst

DAIICHI SANKYO COMPANY, LIMITED <4568> rose for a third straight session. After the bell on April 15, the company announced the divestment of its over-the-counter (OTC) drug subsidiary, Daiichi Sankyo Healthcare, to Suntory Holdings, a move welcomed by the market.

The divestment aims to concentrate management resources on Daiichi Sankyo's core innovative drug business. The share transfer will be phased, with 30% of issued shares to be transferred in June and the process completed by June 2029. The total deal value is 246.5 billion yen. The impact on earnings for the fiscal year ending March 2027 is being assessed, with the company expecting to record a gain on the transfer in the fiscal year ending March 2028, once its voting ratio reaches 30%.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles